Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
David J Adelstein. (2003) Systemic chemotherapy for squamous cell head and neck cancer. Expert Opinion on Pharmacotherapy 4:12, pages 2151-2163.
Read now
Read now
Articles from other publishers (30)
Elena Pallari & Grant Lewison. 2020. Evaluative Informetrics: The Art of Metrics-Based Research Assessment. Evaluative Informetrics: The Art of Metrics-Based Research Assessment
193
212
.
Meena K. Singh & Jerry D. Brewer. (2011) Current Approaches to Skin Cancer Management in Organ Transplant Recipients. Seminars in Cutaneous Medicine and Surgery 30:1, pages 35-47.
Crossref
Crossref
Y. Koh, T.M. Kim, Y.K. Jeon, T.-K. Kwon, J.H. Hah, S.-H. Lee, D.-W. Kim, H.-G. Wu, C.-S. Rhee, M.-W. Sung, C.W. Kim, K.H. Kim & D.S. Heo. (2009) Class III β-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Annals of Oncology 20:8, pages 1414-1419.
Crossref
Crossref
Naoki Ashimori, Benjamin D. Zeitlin, Zhaocheng Zhang, Kristy Warner, Ilan M. Turkienicz, Aaron C. Spalding, Theodoros N. Teknos, Shaomeng Wang & Jacques E. Nör. (2009) TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis. Molecular Cancer Therapeutics 8:4, pages 893-903.
Crossref
Crossref
Sebastien J. Hotte & James R. Wright. (2008) Understanding the Results of Meta-Analyses in the Treatment of Head and Neck Squamous Cell Cancer. Hematology/Oncology Clinics of North America 22:6, pages 1257-1266.
Crossref
Crossref
David J. Adelstein. (2008) Redefining the Role of Induction Chemotherapy in Head and Neck Cancer. Journal of Clinical Oncology 26:19, pages 3117-3119.
Crossref
Crossref
Juan J. Cruz, Alberto Ocaña, Miguel Navarro, Elvira Del Barco & Emilio Fonseca. (2008) New options in the treatment of locally advanced head and neck cancer: Role for induction chemotherapy. Cancer Treatment Reviews 34:3, pages 268-274.
Crossref
Crossref
Pol M. Specenier & Jan B. Vermorken. (2007) Neoadjuvant chemotherapy in head and neck cancer: Should it be revisited?. Cancer Letters 256:2, pages 166-177.
Crossref
Crossref
David Murdoch. (2007) Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Current Opinion in Oncology 19:3, pages 216-221.
Crossref
Crossref
Young-Jin ChoiJooseop ChungHo-Jin ShinGoon-Jae ChoSoo-Geun WangByung-Joo LeeByung-Mann ChoDong-Won KimHak-Jin KimWon Sik LeeYoung-Don JooChang-Hak Sohn. (2007) Induction Chemotherapy of Docetaxel and Cisplatin for the Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. Cancer Research and Treatment 39:1, pages 1.
Crossref
Crossref
J. Bernier & D. Schneider. (2007) Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?. European Journal of Cancer 43:1, pages 35-45.
Crossref
Crossref
David J. Adelstein & Michael LeBlanc. (2006) Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?. Journal of Clinical Oncology 24:17, pages 2624-2628.
Crossref
Crossref
Danny Rischin. 2005. Squamous Cell Head and Neck Cancer. Squamous Cell Head and Neck Cancer
165
170
.
Juan-Carlos Martinez, Clark C. Otley, Scott H. Okuno, Robert L. Foote & Jan L. Kasperbauer. (2004) Chemotherapy in the Management of Advanced Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients: Theoretical and Practical Considerations. Dermatologic Surgery 30:4p2, pages 679-686.
Crossref
Crossref
JUAN-CARLOS MARTINEZ, CLARK C. OTLEY, SCOTT H. OKUNO, ROBERT L. FOOTE & JAN L. KASPERBAUER. (2004) Chemotherapy in the Management of Advanced Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. Dermatologic Surgery 30:4, Part 2, pages 679-686.
Crossref
Crossref
Fred Rosen. 2004. Head and Neck Cancer. Head and Neck Cancer
249
273
.
David J. Adelstein. 2003. Head and Neck Cancer. Head and Neck Cancer
461
474
.
George P. Browman, D. Ian Hodson, Robert J. Mackenzie, Nancy Bestic & Lisa Zuraw. (2001) Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head & Neck 23:7, pages 579-589.
Crossref
Crossref
Volker Rudat & Michael Wannenmacher. (2001) Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer. Seminars in Surgical Oncology 20:1, pages 66-74.
Crossref
Crossref
Kenneth B. Roberts, Nelson Urdaneta, Raul Vera, Andres Vera, Enrique Gutierrez, Yadelis Aguilar, Sara Ott, Ivonne Medina, Pilar Sempere, Sara Rockwell, Alan C. Sartorelli, Diana B. Fischer & James J. Fischer. (2000) Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. International Journal of Cancer 90:4, pages 206-223.
Crossref
Crossref
Jean Bourhis & Jean Pierre Pignon. (1999) META-ANALYSES IN HEAD AND NECK SQUAMOUS CELL CARCINOMA. Hematology/Oncology Clinics of North America 13:4, pages 769-775.
Crossref
Crossref
David J. Adelstein. (1999) INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER. Hematology/Oncology Clinics of North America 13:4, pages 689-698.
Crossref
Crossref
Giuseppe Sanguineti, Renzo Corvò, Maria Pia Sormani, Marco Benasso, Gianmauro Numico, Almalina Bacigalupo, Riccardo Rosso & Vito Vitale. (1999) Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. International Journal of Radiation Oncology*Biology*Physics 44:1, pages 139-147.
Crossref
Crossref
Rakesh M. Nathu, William M. Mendenhall, James T. Parsons, Anthony A. Mancuso & Robert R. Carroll. (1999) Induction chemotherapy and radiation therapy for T4 oropharyngeal carcinoma. Radiation Oncology Investigations 7:2, pages 98-105.
Crossref
Crossref
Aurora Costa, Lisa Licitra, Silvia Veneroni, Maria G. Daidone, Cesare Grandi, Raffaele Cavina, Roberto Molinari & Rosella Silvestrini. (1998) Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. International Journal of Cancer 79:6, pages 619-623.
Crossref
Crossref
Ian F Tannock. (1998) Conventional cancer therapy: promise broken or promise delayed?. The Lancet 351, pages SII9-SII16.
Crossref
Crossref
Aldo Iop, Giuseppe Cartei, Enrico Vigevani, Luigi Clocchiatti, Mauro Mansutti & Angela M. Sibau. (1997) Mitomycin C, Cisplatin, and 5-Fluorouracil for Advanced and/or Recurrent Head and Neck Squamous Cell Carcinomas. American Journal of Clinical Oncology 20:5, pages 515-518.
Crossref
Crossref
David G. Pfister, Ashok R. Shaha & Louis B. Harrison. (1997) The Role of Chemotherapy in the Curative Treatment of Head and Neck Cancer. Surgical Oncology Clinics of North America 6:4, pages 749-768.
Crossref
Crossref
G.P. Stathopoulos, S. Rigatos, P. Papakostas & G. Fountzilas. (1997) Effectiveness of paclitaxel and carboplatin combination in heavily pretreated patients with head and neck cancers. European Journal of Cancer 33:11, pages 1780-1783.
Crossref
Crossref
Henry T. Hoffman, Tim McCulloch, David Gustin & Lucy Hynds Karnell. (1997) Organ Preservation Therapy for Advanced-Stage Laryngeal Carcinoma. Otolaryngologic Clinics of North America 30:1, pages 113-130.
Crossref
Crossref